Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 47% ± 20% | |
lung | 10 studies | 32% ± 13% | |
eye | 6 studies | 41% ± 20% | |
heart | 5 studies | 38% ± 12% | |
kidney | 5 studies | 34% ± 15% | |
intestine | 4 studies | 18% ± 2% | |
adipose | 4 studies | 40% ± 18% | |
peripheral blood | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4320.90 | 1440 / 1445 | 100% | 22.37 | 183 / 183 |
lung | 100% | 4865.79 | 578 / 578 | 97% | 9.55 | 1115 / 1155 |
stomach | 99% | 2917.86 | 356 / 359 | 97% | 13.81 | 278 / 286 |
intestine | 100% | 3945.15 | 964 / 966 | 95% | 9.92 | 503 / 527 |
kidney | 100% | 3478.65 | 89 / 89 | 93% | 14.11 | 837 / 901 |
breast | 100% | 5100.27 | 458 / 459 | 92% | 9.71 | 1024 / 1118 |
pancreas | 98% | 2331.92 | 323 / 328 | 92% | 8.47 | 164 / 178 |
skin | 100% | 6084.94 | 1808 / 1809 | 89% | 8.51 | 421 / 472 |
thymus | 100% | 6890.45 | 652 / 653 | 87% | 11.51 | 526 / 605 |
bladder | 100% | 4623.95 | 21 / 21 | 86% | 8.52 | 434 / 504 |
adrenal gland | 100% | 5459.64 | 258 / 258 | 84% | 6.77 | 193 / 230 |
prostate | 100% | 4147.78 | 244 / 245 | 84% | 8.12 | 423 / 502 |
ovary | 100% | 4203.37 | 180 / 180 | 82% | 4.70 | 352 / 430 |
brain | 88% | 1910.66 | 2335 / 2642 | 93% | 8.08 | 653 / 705 |
uterus | 100% | 5852.20 | 170 / 170 | 78% | 6.09 | 359 / 459 |
liver | 87% | 1409.40 | 196 / 226 | 42% | 2.01 | 169 / 406 |
adipose | 100% | 4729.83 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4389.88 | 1333 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 2664.66 | 239 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 2125.29 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 91% | 2034.59 | 785 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 2646.21 | 700 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 5.34 | 33 / 45 |
eye | 0% | 0 | 0 / 0 | 66% | 4.03 | 53 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 4.62 | 16 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0001816 | Biological process | cytokine production |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0062176 | Biological process | R-loop processing |
GO_0071474 | Biological process | cellular hyperosmotic response |
GO_1904996 | Biological process | positive regulation of leukocyte adhesion to vascular endothelial cell |
GO_0070884 | Biological process | regulation of calcineurin-NFAT signaling cascade |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NFAT5 |
Protein name | Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP) Nuclear factor of activated T cells 5 |
Synonyms | TONEBP KIAA0827 |
Description | FUNCTION: Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Binds the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' . Mediates the transcriptional response to hypertonicity . Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 . Also involved in the DNA damage response by preventing formation of R-loops; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA . . |
Accessions | ENST00000650987.1 ENST00000567239.5 [O94916-4] A0A499FIS8 A0A499FJX5 ENST00000349945.7 [O94916-5] ENST00000393742.7 ENST00000426654.6 [O94916-3] ENST00000567990.5 ENST00000563474.2 J3QKS5 ENST00000565301.2 H3BP21 ENST00000566899.6 O94916 J3KRL6 ENST00000354436.6 [O94916-1] ENST00000627621.3 A0A494C020 |